Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
- PMID: 35552422
- PMCID: PMC9516099
- DOI: 10.1210/clinem/dgac301
Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
Keywords: diabetic ketoacidosis; insulin; ultrafast-acting insulin analogues.
Comment on
-
Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis.JAMA Netw Open. 2022 Apr 1;5(4):e226417. doi: 10.1001/jamanetworkopen.2022.6417. JAMA Netw Open. 2022. PMID: 35389497 Free PMC article.
References
-
- Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40. - PubMed
-
- Vincent M, Nobécourt E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab. 2013;39(4):299-305. - PubMed
-
- Umpierrez GE, Latif K, Stoever J, et al. . Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117(5):291-296. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical